
Multiple variants of SARS-CoV-2 have emerged but the effectiveness of existing COVID-19 vaccines against variants has been reduced, which bring new challenges to the control and mitigation of the COVID-19 pandemic. In this paper, a mathematical model for mutated COVID-19 with quarantine, isolation and vaccination is developed for studying current pandemic transmission. The basic reproduction number R0 is obtained. It is proved that the disease free equilibrium is globally asymptotically stable if R0<1 and unstable if R0>1. And numerical simulations are carried out to illustrate our main results. The COVID-19 pandemic mainly caused by Delta variant in South Korea is analyzed by using this model and the unknown parameters are estimated by fitting to real data. The epidemic situation is predicted, and the prediction result is basically consistent with the actual data. Finally, we investigate several critical model parameters to access the impact of quarantine and vaccination on the control of COVID-19, including quarantine rate, quarantine effectiveness, vaccination rate, vaccine efficacy and rate of immunity loss.
Citation: Fang Wang, Lianying Cao, Xiaoji Song. Mathematical modeling of mutated COVID-19 transmission with quarantine, isolation and vaccination[J]. Mathematical Biosciences and Engineering, 2022, 19(8): 8035-8056. doi: 10.3934/mbe.2022376
[1] | Maryam Al-Yahyai, Fatma Al-Musalhi, Ibrahim Elmojtaba, Nasser Al-Salti . Mathematical analysis of a COVID-19 model with different types of quarantine and isolation. Mathematical Biosciences and Engineering, 2023, 20(1): 1344-1375. doi: 10.3934/mbe.2023061 |
[2] | Shina D. Oloniiju, Olumuyiwa Otegbeye, Absalom E. Ezugwu . Investigating the impact of vaccination and non-pharmaceutical measures in curbing COVID-19 spread: A South Africa perspective. Mathematical Biosciences and Engineering, 2022, 19(1): 1058-1077. doi: 10.3934/mbe.2022049 |
[3] | Yujie Sheng, Jing-An Cui, Songbai Guo . The modeling and analysis of the COVID-19 pandemic with vaccination and isolation: a case study of Italy. Mathematical Biosciences and Engineering, 2023, 20(3): 5966-5992. doi: 10.3934/mbe.2023258 |
[4] | C. K. Mahadhika, Dipo Aldila . A deterministic transmission model for analytics-driven optimization of COVID-19 post-pandemic vaccination and quarantine strategies. Mathematical Biosciences and Engineering, 2024, 21(4): 4956-4988. doi: 10.3934/mbe.2024219 |
[5] | Xiaojing Wang, Yu Liang, Jiahui Li, Maoxing Liu . Modeling COVID-19 transmission dynamics incorporating media coverage and vaccination. Mathematical Biosciences and Engineering, 2023, 20(6): 10392-10403. doi: 10.3934/mbe.2023456 |
[6] | Durward Cator, Qimin Huang, Anirban Mondal, Martial Ndeffo-Mbah, David Gurarie . Individual-based modeling of COVID-19 transmission in college communities. Mathematical Biosciences and Engineering, 2022, 19(12): 13861-13877. doi: 10.3934/mbe.2022646 |
[7] | Rong Yuan, Yangjun Ma, Congcong Shen, Jinqing Zhao, Xiaofeng Luo, Maoxing Liu . Global dynamics of COVID-19 epidemic model with recessive infection and isolation. Mathematical Biosciences and Engineering, 2021, 18(2): 1833-1844. doi: 10.3934/mbe.2021095 |
[8] | Xinmiao Rong, Liu Yang, Huidi Chu, Meng Fan . Effect of delay in diagnosis on transmission of COVID-19. Mathematical Biosciences and Engineering, 2020, 17(3): 2725-2740. doi: 10.3934/mbe.2020149 |
[9] | Hao Wang, Di Zhu, Shiqi Li, Robert A. Cheke, Sanyi Tang, Weike Zhou . Home quarantine or centralized quarantine? A mathematical modelling study on the COVID-19 epidemic in Guangzhou in 2021. Mathematical Biosciences and Engineering, 2022, 19(9): 9060-9078. doi: 10.3934/mbe.2022421 |
[10] | Pannathon Kreabkhontho, Watchara Teparos, Thitiya Theparod . Potential for eliminating COVID-19 in Thailand through third-dose vaccination: A modeling approach. Mathematical Biosciences and Engineering, 2024, 21(8): 6807-6828. doi: 10.3934/mbe.2024298 |
Multiple variants of SARS-CoV-2 have emerged but the effectiveness of existing COVID-19 vaccines against variants has been reduced, which bring new challenges to the control and mitigation of the COVID-19 pandemic. In this paper, a mathematical model for mutated COVID-19 with quarantine, isolation and vaccination is developed for studying current pandemic transmission. The basic reproduction number R0 is obtained. It is proved that the disease free equilibrium is globally asymptotically stable if R0<1 and unstable if R0>1. And numerical simulations are carried out to illustrate our main results. The COVID-19 pandemic mainly caused by Delta variant in South Korea is analyzed by using this model and the unknown parameters are estimated by fitting to real data. The epidemic situation is predicted, and the prediction result is basically consistent with the actual data. Finally, we investigate several critical model parameters to access the impact of quarantine and vaccination on the control of COVID-19, including quarantine rate, quarantine effectiveness, vaccination rate, vaccine efficacy and rate of immunity loss.
Corona Virus Disease 2019 (COVID-19), caused by SARS-CoV-2, has been seriously impacting the world since the end of 2019 [1]. As of April 13, 2022, there have been over 499 million confirmed cases of COVID-19, including over 6 million deaths all over the world [2].
Since the outbreak of COVID-19, many scholars have used different methods to study its transmission [3], such as neural network [4], time series analysis [5] and kinetic modeling [6].
Dynamics models have played a key role in studying the development of things and assessing the impact of different intervention strategies [7,8]. In particular, during the COVID-19 outbreak, multiple dynamics models have been developed to investigate its spread and control.
Before the availability of effective vaccines, non-pharmaceutical interventions strategies (NPIs) were taken into account controlling the pandemic transmission, such as lockdowns, the use of face-masks in public, quarantine of close contacts, isolation of confirmed cases, among others [9]. Ngonghala et al. [10] proposed a detailed mathematical model of COVID-19 that combined quarantine and isolation to assess the impact of NPIs on combating and mitigating the burden of COVID-19. Their results indicated that the early implementation (and enhancement of effectiveness) of these intervention measures is obviously critically-important to curtail COVID-19 transmission. NPIs could mitigate the spread of the virus, but it is not the permanent solution to the problem [11].
Since January 2021, more than ten types of vaccines against SARS-CoV-2 have been fully or limitedly approved and used clinically [12]. And many countries are starting vaccination campaigns, which has improved the global epidemic to some extent [13]. Iboi et al. [14] developed a mathematical model for assessing the impact of an anti-COVID-19 vaccine on the spread of COVID-19 in the United States. This study showed that the prospect of eliminating COVID-19 in the US using the imperfect hypothetical vaccine is promising. Moreover, the integration of vaccination and physical distancing interventions, can result in better pandemic prevention [15]. Zou et al. [16] established a multiple patch coupled model to explore the impact of vaccination and NPIs on the control of COVID-19 and the results indicated that effective vaccination has positive impact on prevention of pandemic transmission and the joint implementation of vaccination and quarantine ensures the controllability of the epidemic.
However, new variants of COVID-19 with high transmission rates are spreading around the world and vaccines are less effective in preventing infection than they were for earlier virus variants, which have brought new challenges to the elimination of pandemic [17,18]. Recently, Li et al. [19] developed a mathematical model of COVID-19 transmission with imperfect vaccination to explore effective and reasonable plans to prevent the spread of Delta variant. Their results found that the optimal control measure is to dynamically adjust three control measures, namely, vaccination, isolation and nucleic acid testing, to achieve the lowest number of infections at the lowest cost. Truszkowska et al. [20] developed an extremely detailed mathematical model, to study the combined effect of booster shot administration and testing practices in this stage of the pandemic.
Motivated by the implement of NPIs, the promotion of vaccination strategy and the emerging of variants of COVID-19, we consider a mathematical model for mutated COVID-19 with quarantine, isolation and vaccination, make some theoretical analysis of the model, verify the applicability of the model by the COVID-19 pandemic mainly caused by Delta variant in South Korea, and finally, assess the impact of quarantine and vaccination on eliminating mutated COVID-19 transmission.
The organization of this paper is as follows. In Section 2, the basic model formulation is discussed. In Section 3 we derive the disease free equilibrium and basic reproduction number R0. The local asymptotic stability and global asymptotic stability of the model at the disease free equilibrium are proved. In Section 4, the numerical simulation is carried out to verify the correctness of the proof. In Section 5, according to the epidemic data of COVID-19 in South Korea from August 22 to October 20, 2021, unknown parameters are obtained by two-stage fitting, and then the epidemic is predicted, which is compared with the real data to verify the applicability of the model. In Section 6, the impact of quarantine and vaccination on the control of COVID-19 are assessed by numerical simulation. Finally, in Section 7, we give some discussions.
We develop an epidemic model, which incorporates the main interventions being implemented to curtail COVID-19 transmission (such as quarantine, isolation and vaccination). We stratify the population as susceptible (Su), vaccinated (Vu), exposed (Eu), asymptomatically-infectious (Ia), symptomatically-infectious (Iu) and recovered (R) compartments, and further stratify the population to include quarantined susceptible (Sq), quarantined vaccinated (Vq), quarantined exposed (Eq) and hospitalized (Ih) compartments, so that the total population of the model N(t) is divided into 10 compartments, namely
N(t)=Su(t)+Sq(t)+Vu(t)+Vq(t)+Eu(t)+Eq(t)+Iu(t)+Ih(t)+Ia(t)+R(t). |
For developing the mathematical model, the basic assumptions are as follows:
(ⅰ) The recruitment rate (either by birth or by immigration) of the population is given by a constant rate Λ and they are all susceptible.
(ⅱ) Susceptible individuals move to exposed compartment by effective contacts with exposed, symptomatically-infectious or asymptomatically-infectious individuals and after latency period, they become infectious and move to infectious compartment.
(ⅲ) After recovery the individuals have immunity to COVID-19 in a short time.
(ⅳ) A part of vaccinated individuals will lose their immunity and rejoin the susceptible compartment.
(ⅴ) After the immunity period, the vaccinated individuals become susceptible again.
(ⅵ) Hospitalization is completely effective.
(ⅶ) The exposed individuals and the asymptomatically-infectious individuals are also infectious, but the infectivity is weaker than that of symptomatically-infectious individuals, measuring by coefficients ηu and ηa respectively(0<ηu,ηa<1).
(ⅷ) The contact rate c is the same for the individuals in symptomatically-infectious Iu, non-quarantined exposed Eu and the asymptomatically-infectious Ia compartments.
(ⅸ) The latency period is defined as the days from exposure to the onset of illness.
(ⅹ) The asymptomatically-infectious compartment Ia includes those with mild symptoms or no clinical symptoms of the COVID-19 at the end of the latency period.
(ⅹⅰ) Considering that the number of people that an infected person can contact per unit time is finite, a more realistic standard incidence is used in the model.
(ⅹⅱ) The vaccinated individuals will not lose immunity during the quarantine period.
(ⅹⅲ) If the quarantine individuals have symptoms, they will be sent to the hospital.
The assumptions above lead to the flow diagram of the model depicted in Figure 1.
It is worth noting that hospitalization indicates isolation at the hospital in this study. With contact tracing, a proportion, q, of individuals exposed to the virus is quarantined. The quarantined individuals, if infected, move to the compartment Eq and and the remaining individuals can either stay in compartment Vq or Sq, depending on whether they are vaccinated or not. For those individuals who are missed from contact tracing, the situation is similar.
The model is given by the following deterministic system of nonlinear differential equations.
dSudt=Λ−[β(1−q)λ+βqλ+(1−β)qλ+ξv+d]Su+ωSq+ηvVu,dSqdt=−(ω+θβλ+d)Sq+(1−β)qλSu,dVudt=−[ηv+εvβ(1−q)λ+εvβqλ+p2(1−β)qλ+d]Vu+ξvSu+p1ωVq,dVqdt=−(p1ω+εvθβλ+d)Vq+p2(1−β)qλVu,dEudt=−[αu+f1σu+f2σu+(1−f1−f2)σu+d]Eu+β(1−q)λSu+εvβ(1−q)λVu,dEqdt=−[rσq+(1−r)σq+d]Eq+βqλSu+θβλSq+εvβqλVu+εvθβλVq+αuEu,dIudt=−(ϕu+δu+γu+d)Iu+f1σuEu,dIhdt=−(δh+γh+d)Ih+f2σuEu+rσqEq+ϕuIu+σaIa,dIadt=−(σa+δa+γa+d)Ia+(1−f1−f2)σuEu+(1−r)σqEq,dRdt=γuIu+γhIh+γaIa−dR. | (2.1) |
where λ(t)=c(Iu+ηuEu+θηuEq+ηaIa)Su+Vu+Eu+Iu+Ia+R+θ(Sq+Eq+Vq).
The initial conditions for system (2.1) are as follows:
Su(0)=Su0≥0,Sq(0)=Sq0≥0,Vu(0)=Vu0≥0,Vq(0)=Vq0≥0,Eu(0)=Eu0≥0,Eq(0)=Eq0≥0,Iu(0)=Iu0≥0,Ih(0)=Ih0≥0,Ia(0)=Ia0≥0,R(0)=R0≥0. | (2.2) |
The state variables and parameters of the model are described in Tables 1 and 2, respectively.
State variable | Description |
Su | Population of non-quarantined susceptible individuals |
Sq | Population of quarantined susceptible individuals |
Vu | Population of non-quarantined vaccinated individuals |
Vq | Population of quarantined vaccinated individuals |
Eu | Population of non-quarantined exposed individuals |
Eq | Population of quarantined exposed individuals |
Iu | Population of non-hospitalized symptomatically-infectious individuals |
Ih | Population of hospitalized symptomatically-infectious individuals |
Ia | Population of asymptomatically-infectious individuals with mild or no clinical symptoms of the disease |
R | Population of recovered individuals |
Parameter | Description | Values |
c | Effective contact rate | 0.1 |
β | Probability of infection per contact | 0.5 |
q | Proportion of infectious individuals quarantined at time of exposure | 0.05 |
ξv | Vaccination rate (the reciprocal of the time during which everyone has completed vaccination) | 0.8 |
ηv | Rate of immunity loss after vaccination (1/ηv is the mean duration of vaccine immunity) | 0.56 |
εv | Ineffectiveness of vaccine against COVID-19 variants | 0.14 |
ηu | Modification parameter accounting for the relative infectiousness of individuals in the Eu compartment in relation to individuals in the Iu compartment (0<ηu<1) | 0.1 |
ηa | Modification parameter accounting for the relative infectiousness of individuals in the Ia compartment in relation to individuals in the Iu compartment (0<ηa<1) | 0.1 |
θ | Ineffectiveness of quarantine | 0.5 |
ω | Rate at which individuals in the Sq compartment revert to the Su compartment (1/ω is the duration of quarantine) | 0.5 |
αu | Rate at which individuals in the Eu compartment are detected and placed in quarantine | 0.116 |
1σu(1σq) | Latency period for non-quarantined (quarantined) exposed individuals | 5.1 |
σa | Rate at which individuals in the Ia compartment are detected and hospitalized | 0.309 |
f1 | Proportion of individuals in the Eu compartment who progress to the Iu compartment at the end of the incubation period (f1+f2<1) | 0.4 |
f2 | Proportion of individuals in the Eu compartment who progress to the Ih compartment at the end of the incubation period (f1+f2<1) | 0.2 |
1−f1−f2 | Proportion of individuals in the Eu compartment who progress to the Ia compartment | 0.4 |
r(1−r) | Proportion of individuals in the Eq compartment who move to the Ih (Ia) compartment | 0.7 |
ϕu | Hospitalization rate of individuals in the Iu compartment | 0.2 |
p1 | Modification parameter accounting for the relative release rate of individuals in the Vu compartment in relation to individuals in the Su compartment | 0.5 |
p2 | Modification parameter accounting for the relative quarantine rate of individuals in the Vu compartment in relation to individuals in the Su compartment | 1 |
γu | Recovery rate for individuals in the Iu compartment | 0.1 |
γh | Recovery rate for individuals in the Ih compartment | 0.125 |
γa | Recovery rate for individuals in the Ia compartment | 0.13978 |
δu | Disease-induced mortality rate for individuals in the Iu compartment | 0.015 |
δh | Disease-induced mortality rate for individuals in the Ih compartment | 0.015 |
δa | Disease-induced mortality rate for individuals in the Ia compartment | 0.075 |
Λ | Recruitment rate | 20 |
d | Natural death rate | 0.2 |
Let H(t)=(Su(t),Sq(t),Vu(t),Vq(t),Eu(t),Eq(t),Iu(t),Ih(t),Ia(t) ,R(t)).
Lemma 1. Consider the initial data Hi(0)≥0,i=1,2,...,10. Then, for any t>0, we have the non-negative solution for the system (2.1).
Proof. Consider t1=sup{t>0:Hi(t)>0,i=1,2,...,10}. So, t1>0. The following result is given using the first equation of the model (2.1),
dSudt=Λ+ωSq+ηvVu−(d+ξv)Su−[βλ+(1−β)qλ]Su≥Λ−(d+ξv)Su−[βλ+(1−β)qλ]Su. |
Then, it can be written as,
ddt{Su(t)exp[(d+ξv)t+∫t0[βλ(ρ)+(1−β)qλ(ρ)]dρ]}≥Λexp[(d+ξv)t+∫t0[βλ(ρ)+(1−β)qλ(ρ)]dρ]. |
Thus,
Su(t1)exp[(d+ξv)t1+∫t10[βλ(ρ)+(1−β)qλ(ρ)]dρ]−Su(0)≥∫t10Λexp[(d+ξv)x+∫x0[βλ(ζ)+(1−β)qλ(ζ)]dζ]dx, |
so that
Su(t1)≥(Su(0)+∫t10Λexp[(d+ξv)x+∫x0[βλ(ζ)+(1−β)qλ(ζ)]dζ]dx)×exp[−(d+ξv)t1−∫t10[βλ(ρ)+(1−β)qλ(ρ)]dρ]>0. |
For the remaining equations, we take the same steps to show Hi(t)>0 (i=2,3,...,10) for every t>0.
Let the closed and biologically feasible region be Ω, shown by Ω={(Su,Sq,Vu,Vq,Eu,Eq,Iu,Ih,Ia,R)∈R10+,0≤Su,Sq,Vu,Vq,Eu,Eq,Iu,Ih,Ia,R,N≤Λd}.
Next, we present the following results for this feasible region.
Lemma 2. The region Ω is a positively invariant and attracting region for system (2.1) with the non-negative initial conditions (2.2).
Proof. Summing up the ten equations in system (2.1) and considering that all parameters of the model are non-negative, we get
dN(t)dt=Λ−dN−δaIa−δuIu−δhIh≤Λ−dN. |
Now integrating both sides of the above inequality and using the comparison theorem [21], we obtain
0<N(t)≤Λd+(N(0)−Λd)e−dt. |
Clearly, 0<N(t)≤Λd, as t→∞. If N(0)≤Λd, then N(t)≤Λd. Thus, the region Ω is positive invariant and attracts all the possible solutions of the model (2.1). We will consider the dynamic behavior of model (2.1) on Ω.
Obviously, the model (2.1) always has a disease free equilibrium (DFE) P0(S0,0,V0,0,0,0,0,0,0,0), where
S0=Λ(ηv+d)d(ηv+d+ξv),V0=Λξvd(ηv+d+ξv). |
The basic reproduction number R0 will be calculated using the next generation matrix method [22,23]. It follows that the next generation operator matrices, F and V for the new infection terms and the transition terms, are given, respectively,
F=(ηuM1θηuM1M10ηaM1ηuM2θηuM2M20ηaM2000000000000000),andV=(K10000−αuK2000−f1σu0K300−f2σu−rσq−ϕuK40−(1−f1−f2)σu−(1−r)σq00K5), |
where, M1=cβ(1−q)S0+εvV0Λ/d, M2=cβqS0+εvV0Λ/d, K1=σu+αu+d, K2=σq+d, K3=ϕu+γu+δu+d, K4=γh+δh+d, K5=σa+γa+δa+d. By the definition of the basic reproduction number R0, we get
R0=ρ(FV−1)=REu+REq+RIu+RIa, | (3.1) |
where,
REu=ηuK1M1,REq=θηu(αuK1K2M1+1K2M2),RIu=f1σuK1K3M1,RIa=ηa[((1−f1−f2)σuK1K5+αu(1−r)σqK1K2K5)M1+(1−r)σqK2K5M2]. |
The quantity R0 is the basic reproduction number of the model (2.1). It measures the average number of the new COVID-19 infections generated by a typical infective individual introduced into a population where basic public health interventions (quarantine, isolation, vaccination, etc.) are implemented.
In this section, we analyse the stability of the model (2.1) at the DFE. First, we show the local stability of system (2.1) at the DFE.
Theorem 1. The DFE of the model (2.1) is locally asymptoticallystable if R0<1, and unstable if R0>1.
Proof. Let ˉH=(Eu(t),Eq(t),Iu(t),Ia(t),Su(t),Sq(t),Vu(t),Vq(t),Ih(t),R(t)), we can obtain the Jacobian matrix of the system corresponding to ˉH at P0, and partition the matrix.
It is given by
J(P0)=(−K1+ηuM1θηuM1M1ηaM1000000αu+ηuM2−K2+θηuM2M2ηaM2000000f1σu0−K30000000(1−f1−f2)σu(1−r)σq0−K5000000∗∗∗∗−(ξv+d)ωηv000∗∗∗∗0−(ω+d)0000∗∗∗∗ξv0−(ηv+d)p1ω00∗∗∗∗000−(p1ω+d)00∗∗∗∗0000−(δh+γh+d)0∗∗∗∗0000γh−d)=(J1J2J3J4) |
Using the Laplace theorem, it's easy to find that the eigenvalues of J(P0) are determined by the eigenvalues of J1 and J4.
Consider the eigenvalues of J4 first.
It is obvious that J4 has always four negative eigenvalues λ1=−d, λ2=−(δh+γh+d), λ3=−(p1ω+d) and λ4=−(ω+d), and the other eigenvalues of J4 are determined by the equation
λ2+(ξv+ηv+2d)λ+ξvd+ηvd+d2=0. |
Clearly, λ5+λ6=−(ξv+ηv+2d)<0, λ5⋅λ6=ξvd+ηvd+d2>0, so λ5 and λ6 are both negative.
Then consider the eigenvalues of J1. Through calculation and integration, we have
det(λE−J1)=a0λ4+a1λ3+a2λ2+a3λ+a4=0, |
where,
a0=1,a1=K1+K2+K3+K5−ηuM1−θηuM2,a2=K5(K2−θηuM2)−(1−r)σqηaM2+(K1−ηuM1)(K2+K5−θηuM2)+K3(K1+K2+K5−ηuM1−θηuM2)−ηa(1−f1−f2)σuM1+θηuM1(−αu−ηuM2)−f1σuM1,a3=K3[K5(K2−θηuM2)−(1−r)σqηaM2+(K1−ηuM1)(K2+K5−θηuM2)−ηa(1−f1−f2)σuM1+θηuM1(−αu−ηuM2)]+K1[K5(K2−θηuM2)−(1−r)σqηaM2]−ηuK2K5M1−αuθηuK5M1−ηaαu(1−r)σqM1−ηa(1−f1−f2)σuK2M1−f1σu(K2+K5)M1,a4=K3{K1[K5(K2−θηuM2)−(1−r)σqηaM2]−ηuK2K5M1−αuθηuK5M1−ηaαu(1−r)σqM1−ηa(1−f1−f2)σuK2M1−f1σuK2K5M1}. |
If R0<1, we have ηuK1M1<1 and θηuK2M2<1, so it can be observed that a1>0.
Because of a4K1K2K3K5=1−R0, we obtain a4>0 if R0<1.
Due to
a3K1K2K3K5=1K1[1−θηuK2M2−ηa(1−r)σqK2K5M2]+1K5(1−ηuK1M1−αuθηuK1K2M1−θηuK2M2−f1σuK1K3M1)+1K2[1−ηuK1M1−f1σuK1K3M1−ηa(1−f1−f2)σuK1K5M1]+1K3{1−ηuK1M1−αuθηuK1K2M1−θηuK2M2−ηa[(1−f1−f2)σuK1K5+αu(1−r)σqK1K2K5]M1−ηa(1−r)σqK2K5M2}>1K1(1−REq−RIa)+1K5(1−REu−REq−RIu)+1K2(1−REu−RIu−RIa)+1K3(1−REu−REq−RIa)>0, |
then a3>0.
Meanwhile, we can also obtain that
a1a2−a3=(K1+K2+K5−ηuM1−θηuM2)[K5(K2−θηuM2)−(1−r)σqηaM2+K1K5−ηuK5M1−ηa(1−f1−f2)σuM1]+(K1+K2+K3+K5−ηuM1−θηuM2)[K3(K1+K2+K5−ηuM1−θηuM2)−f1σuM1]+(K1+K2+K5−ηuM1−θηuM2)[K1(K2−θηuM2)−ηuK2M1−αuθηuM1]−K1K5(K2−θηuM2)+ηuK2K5M1+αuθηuK5M1+(1−r)σqηaM2−ηaαu(1−r)σqM1−ηa(1−f1−f2)σuK2M1+f1σu(K2+K5)M1>(K1+K2+K5−ηuM1−θηuM2)[K5(K2−θηuM2)−(1−r)σqηaM2+K1K5−ηuK5M1−ηa(1−f1−f2)σuM1]+(K1+K2+K3+K5−ηuM1−θηuM2)K3(K2+K5−θηuM2)+(K1+K2−ηuM1−θηuM2)[K1(K2−θηuM2)−ηuK2M1−αuθηuM1]+K5K1(K2−θηuM2)−K5ηuK2M1−K5αuθηuM1−K1K5(K2−θηuM2)+ηuK2K5M1+αuθηuK5M1=(K1+K2+K5−ηuM1−θηuM2)[K5(K2−θηuM2)−(1−r)σqηaM2+K1K5−ηuK5M1−ηa(1−f1−f2)σuM1]+(K1+K2+K3+K5−ηuM1−θηuM2)K3(K2+K5−θηuM2)+(K1+K2−ηuM1−θηuM2)[K1(K2−θηuM2)−ηuK2M1−αuθηuM1]>0. |
The first inequality is established due to (ηuK1+f1σuK1K3)M1<1, if R0<1. It is apparent from the above analysis that it satisfies the Routh-Hurwitz stability criterion. Thus, it follows that the DFE P0 is locally asymptotically stable if R0<1. On the other hand, we have a4K1K2K3K5=1−R0<0 if R0>1, then a4<0, which shows that at least one of the eigenvalues of J1 is positive. Therefore, the DFE P0 is unstable if R0>1. This completes the proof.
Theorem 2. The DFE of the model (2.1) is globallyasymptotically stable in Ω if R0<1.
Proof. Let X=(Eu,Eq,Iu,Ih,Ia)T. It can be stated that
dXdt≤(F−V)X, |
with F and V are matrices on calculating R0. Let u=(ηu,θηu,1,0,ηa). It then follows from the fact R0=ρ(FV−1)=ρ(V−1F) and direct calculation that u is a left eigenvector of the matrix V−1F, i.e., uV−1F=R0u.
Consider a Liapunov function
L0=uV−1X. |
Differentiating the above equation, we have
dL0dt=uV−1dXdt≤uV−1(F−V)X=u(R0−1)X. |
If R0<1, the equality dL0dt=0 implies that uX=0. This leads to Eu=Eq=Iu=Ia=0 by noting that all components of u except for the fourth element are positive.
Clearly, let
E={(Su,Sq,Vu,Vq,Eu,Eq,Iu,Ih,Ia,R)∈Ω∣dL0dt=0}={Eu=Eq=Iu=Ia=0}, |
then the largest invariant set of the system in E is M={Eu=Eq=Iu=Ia=0}. By LaSalle's Invariant Principle [24], we get limt→∞Eu(t)=limt→∞Eq(t)=limt→∞Iu(t)=limt→∞Ia(t)=0. Then, it is easy to solve the 8th equation of the model (2.1), and we have
Ih(t)=[Ih0+∫t0(f2σuEu(τ)+rσqEq(τ)+ϕuIu(τ)+σaIa(τ))eK4τdτ]e−K4t. |
Using L'Hospital's rule,
limt→∞Ih(t)=limt→∞f2σuEu(t)+rσqEq(t)+ϕuIu(t)+σaIa(t)K4=0. |
In a similar way, for the 2nd, 4th and 10th equation of the model (2.1), we have limt→∞Sq(t)=limt→∞Vq(t)=limt→∞R(t)=0. Hence, we can obtain the limit system of (2.1) as follows.
dSudt=Λ−(ξv+d)Su+ηvVu,dVudt=ξvSu−(ηv+d)Vu. | (3.2) |
It is easy to solve that
Su(t)=S0+(Su(0)−Λ(ηv+d)d(ηv+d+ξv))e−(ηv+d+ξv)t,Vu(t)=V0+(Vu(0)−Λξvd(ηv+d+ξv))e−(ηv+d+ξv)t. |
Clearly, we can get limt→∞Su(t)=S0, limt→∞Vu(t)=V0, so (S0,V0) is globally attractive for the limit system (3.2). By discussion of linearization systems for (3.2), it can be known that (S0,V0) is locally asymptotically stable if R0<1. Combining global attraction of (S0,V0), we can obtain that (S0,V0) is globally asymptotically stable for the limit systems (3.2). It follows that P0(S0,0,V0,0,0,0,0,0,0,0) is globally attractive for the original system (2.1). In addition, combining Theorem 1, we eventually concluded that P0 is globally asymptotically stable if R0<1.
In this section, we present the numerical solution of the system (2.1).
We can get R0=0.0147<1 and P0=(48.7179,0,51.2821,0,0,0,0,0,0,0,0,0) by using the parameter values given in Table 2. The dynamical behavior for different initial conditions of model (2.1) is presented in Figure 2. It's easy to find that, Su tends to 48.7179, Sq tends to 0, Vu tends to 51.2821, Vq tends to 0, Eu tends to 0, Eq tends to 0, Iu tends to 0, Ih tends to 0, Ia tends to 0, and R tends to 0. It shows that system (2.1) has a DFE and it is globally asymptotically stable with different initial values when R0<1. The numerical simulation results support the case stated in Theorem 2.
In order to show that the model is practical, the COVID-19 pandemic mainly caused by Delta variant in South Korea is analysed and verified in this section. The experimental data come from the Central Disaster Management Headquarters of Korea [25]. About 97% of confirmed cases were infected by the Delta variant on August 22, 2021 [26], so August 22, 2021 is chosen as the starting date of the data set. The data in this paper is the official data of COVID-19 in Korea from August 22, 2021 to October 20, 2021.
In order to verify the training effect, the data set is divided into training set (from August 22 to October 14, 2021, 54 days in total) and verification set (from October 15 to 20, 2021, 6 days in total) according to the ratio of 9:1. The unknown parameters of the model are obtained by fitting the real data of the training set, and the prediction effect of the model is tested by using the real data of the verification set. According to the Korea Disease Control and Prevention Agency (KDCA) [27], since September 24, 2021, the vaccinated individuals can be exempted from quarantine if they show no symptoms after close contact with the confirmed individuals. Therefore, this paper considers the training set in two stages. The first stage is from August 22, 2021 to September 23, 2021, and the second stage is from September 24, 2021 to October 14, 2021.
Before fitting the parameters, we fix some parameters from previous literatures and studies to reduce the complexity.
Since the recommended duration in quarantine for people suspected of being exposed to COVID-19 in South Korea was 14 days [28], we set ω = 1/14 per day. Further, Zhang et al. estimated that the mean incubation period of Delta variant was 4.4 days [29], which was shorter than that of the original strain reported by Yin et al. (4.4 vs. 6.8) [30]. Thus, we consider σu = σq = 1/4.4 per day. Some studies have suggested that most COVID-19 infections (over 95.6%) show moderate, mild, or asymptomatic infections, about 3.08% show severe symptoms (but without requiring ICU admission), and 1.32% show critically-severe symptoms requiring ICU admission [31,32]. Consequently, we set f2 = 0.044. According to [33], the proportion of asymptomatically-infectious individuals is 16%. Hence, we get f1 = 0.80304 and 1−f1−f2 = 0.15296 respectively. The modification parameter for the relative infectiousness of asymptomatically-infectious individuals (ηa) was estimated from [31,34] to be 0.5, so we set ηa=0.5. Due to the strict quarantine policy in South Korea [28], we assume that the ineffectiveness of quarantine θ=0. The average lifespan of Korean is 83.3 years [35]. Therefore, we have the natural death rate d=1/(83.3×365) per day. The latest total population of South Korea is about N(0) = 51,821,669 [36], hence, the recruitment rate Λ is obtained from Λ/d = N(0), so Λ=1704.41 per day. The World Health Organization (WHO) explicitly wrote in the document [37] that the critical characteristic or the minimal requirement is to confer protection for at least six months. Therefore, we assume that the average duration of vaccine immunity is 180 days, then ηv=1/180 per day. It can be seen from [38] that COVID-19 vaccine was on average 86.6% effective in preventing infections, so we select εv = 0.134. According to [39], the maximum and minimum values of disease-induced mortality rate from August 22 to October 14 were 0.93% and 0.82%, respectively, and we take the average value as 0.875%. Thus we set δu=δh=0.00875 per day. To obtain estimation for δa, we assume that δa=0.5δu (so that δa=0.004375 per day). According to [39] and calculation, vaccination rate ξv is about 7.6×10−3 per day. As can be seen from [27], the vaccinated individuals, like the unvaccinated individuals, needed to be quarantined, so p1=p2=1 in the first stage. However, since the vaccinated individuals did not need to be quarantined since September 24 [27], p1=p2=0 in the second stage. In addition, we fix the initial hospitalized population Ih(0) and total population N(0) as 27,959 and 51,821,669 respectively according to the data information. From [40], it can be known the number of newly confirmed cases per day confirmed by temporary screening. Let the vaccination proportion on August 22 be ξ. According to [41], ξ = 22.5%. The default parameter values and the initial values of state variables are given in Tables 3 and 4, respectively.
Parameter | Default values | Reference | Parameter | Default values | Reference |
Λ | 1704.41 | [35,36] | 1−f1−f2 | 0.15296 | [31,32,33] |
d | 1/(83.3×365) | [35] | r | 0.7 | [10] |
ξv | 7.6×10−3 | [39] | σa | 0.2435 | [10] |
ηv | 1/180 | [37] | ϕu | 1/5 | [10,31] |
εv | 0.134 | [38] | p1 | 1 0 | [27] |
ηu | 0.5 | Assumed | p2 | 1 0 | [27] |
ηa | 0.5 | [31,34] | γu | 1/10 | [10,31] |
θ | 0 | [28] | γh | 1/8 | [10,31] |
ω | 1/14 | [28] | γa | 0.13978 | [42] |
σu(σq) | 1/4.4 | [29] | δu | 0.00875 | [39] |
f1 | 0.80304 | [31,32,33] | δh | 0.00875 | [39] |
f2 | 0.044 | [31,32] | δa | 0.004375 | [39] |
Variable | Initial value | Reference |
Su | 39,465,104 | (1−ξ)(N(0)−Sq(0)−Vq(0)−Eu(0)−Eq(0)−Ih(0)−Iu(0)−Ia(0)−R(0)) |
Sq | 478,691 | Derived from the number of newly confirmed cases per day confirmed by temporary screening, ω and ξ |
Vu | 11,457,611 | ξ(N(0)−Sq(0)−Vq(0)−Eu(0)−Eq(0)−Ih(0)−Iu(0)−Ia(0)−R(0)) |
Vq | 138,975 | Derived from the number of newly confirmed cases per day confirmed by temporary screening, ω and ξ |
Eu | 1664 | Derived from Iu(0), Ia(0) and σu |
Eq | 4852 | Derived from the number of newly confirmed cases per day confirmed by temporary screening and σq |
Iu | 1751 | Derived from the proportion of symptomatically-infectious individuals, Ih(0) and ϕu |
Ih | 27,959 | Official data |
Ia | 333 | Derived from the proportion of asymptomatically-infectious individuals, Ih(0) and σa |
R | 244,729 | Derived from official data and the proportion of newly confirmed cases per day confirmed by temporary screening |
The remaining parameters are obtained by fitting the data in the training set. The model is solved by using lsqcurvefit function in Matlab, which utilizes a nonlinear least squares method to estimate parameters. The fitting parameters in two stages are given in Table 5.
Parameter | Fitted value of the first stage | Fitted value of the second stage |
c | 10.7392 | 24.6129 |
β | 0.1037 | 0.1216 |
q | 0.7727 | 1 |
αu | 0.0714 | 0.3156 |
In order to evaluate the fitting and prediction effect, the mean absolute percentage error (MAPE) is used in this paper. MAPE between the cumulative number of confirmed cases obtained by model fitting and the actual data in the training set is used to evaluate the fitting effect of the model. Similarly, MAPE between the cumulative number of confirmed cases obtained by model prediction and actual data in the verification set is used to evaluate the prediction effect of the model. MAPE is expressed as:
MAPE=1nn∑t=1|ˆCt−CtCt|×100% | (5.1) |
where, Ct is the actual cumulative number of confirmed cases on the t th day.
The best fits to the reported data of the two stages via our model are depicted in Figure 3. Further, using the above parameters, we make a prediction on the verification set, and the prediction result is shown in Figure 4. As can be seen, there is a good agreement between the prediction result and the real data. The fitting and prediction effect of the model are shown in Table 6.
Fitting effect of the first stage | Fitting effect of the second stage | Prediction effect | |
MAPE | 0.23% | 0.22% | 0.047% |
For simplicity of presentation, we make θ1=1−θ and ε=1−εv, i.e., θ1 is quarantine effectiveness and ε is vaccine efficacy.
First of all, we simulate the impact of the quarantine rate (q) on the spread of COVID-19. As shown in the Figure 5(a), if the quarantine rate decreases, the cumulative number of deaths will sharply increase, which negatively affects prevention and control of COVID-19.
Next, we consider the impact of quarantine effectiveness (θ1) on COVID-19 transmission. The results are shown in Figure 5(b), which imply that implementing strict quarantine measures is an effective means to prevent the development of the COVID-19 pandemic.
We firstly assess the impact of the vaccination rate (ξv) on the prevention of COVID-19 transmission. The simulation results are presented in Figure 6(a), which show that a significantly large increasement in vaccination rate is necessarily needed for the control of COVID-19.
As can be seen from the comparison results in Figure 6(b), when we increase vaccine efficacy (ε), the cumulative number of deaths markedly decreases. Meanwhile, it is easy to find that the stronger the effectiveness of vaccine, the faster the elimination of pandemic.
Finally, we simulate the impact of rate of immunity loss (ηv) on dynamic transmission of the COVID-19. Depicted in Figure 6(c), the longer duration of vaccine immunity can have a better suppression effect on the spread of pandemic.
A mathematical model for mutated COVID-19 combining quarantine, isolation and vaccination is established in this paper, and it is proved that the model is globally asymptotically stable at the DFE if R0<1, and the correctness of this result is verified by numerical simulation. The unknown parameters are obtained by fitting the COVID-19 epidemic data in South Korea from August 22 to October 14, 2021 in stages, and MAPE in two stages are 0.23 and 0.22%, respectively. The fitting effect of the model is satisfying. In the prediction of the data set from October 15 to October 20, 2021, MAPE is 0.047%, and the prediction effect is satisfactory, which also shows that the model is feasible. Numerical simulations indicate that it is essential to implement strict quarantine measures and strengthen contact tracing for combating the spread of COVID-19. Meanwhile, increasing vaccination rate and getting the vaccines with more effective and the longer duration of vaccine immunity have positive impact on the prevention of pandemic transmission.
However, there are still many issues worthy of further study. For instance, most parameters (such as quarantine rate and vaccination rate) are dynamically changing during the development of COVID-19, but these characteristics are not taken into account in the current model. Thus, dynamic model with stochastic parameters deserves further study. Besides, the severity of infection is different in reality, so we can consider further the confirmed individuals with common and severe symptoms. These problems are of great interest which can be left for studying in the near further.
The authors are grateful to the editors and the reviewers for their valuable comments and suggestions. This work was supported by the Fundamental Research Funds for the Central Universities (NO.2572018BC20).
The authors declare there is no conflict of interest.
[1] |
Q. Li, X. H. Guan, P. Wu, X. Y. Wang, L. Zhou, Y. Q. Tong, et al., Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia, N. Engl. J. Med., 382 (2020), 1199–1207. https://doi.org/10.1056/NEJMoa2001316 doi: 10.1056/NEJMoa2001316
![]() |
[2] | World Health Organization, WHO coronavirus disease (COVID-19) dashboard, 2022. Available from: https://covid19.who.int/. |
[3] |
C. C. John, V. Ponnusamy, S. K. Chandrasekaran, R. Nandakumar, A survey on mathematical, machine learning and deep learning models for COVID-19 transmission and diagnosis, IEEE Rev. Biomed. Eng., 15 (2021), 325–340. https://doi.org/10.1109/RBME.2021.3069213 doi: 10.1109/RBME.2021.3069213
![]() |
[4] |
Z. H. Yu, A. Sohail, T. A. Nofal, J. M. R. S. Tavares, Explainability of neural network clustering in interpreting the COVID-19 emergency data, Fractals, (2021). https://doi.org/10.1142/S0218348X22401223 doi: 10.1142/S0218348X22401223
![]() |
[5] |
Z. H. Yu, A. S. G. Abdel-Salam, A. Sohail, F. Alam, Forecasting the impact of environmental stresses on the frequent waves of COVID19, Nonlinear Dyn., 106 (2021), 1509–1523. https://doi.org/10.1007/s11071-021-06777-6 doi: 10.1007/s11071-021-06777-6
![]() |
[6] |
Z. H. Yu, R. Ellahi, A. Nutini, A. Sohail, S. M. Sait, Modeling and simulations of CoViD-19 molecular mechanism induced by cytokines storm during SARS-CoV2 infection, J. Mol. Liq., 327 (2021), 114863. https://doi.org/10.1016/j.molliq.2020.114863 doi: 10.1016/j.molliq.2020.114863
![]() |
[7] |
Z. H. Yu, H. X. Gao, D. Wang, A. A. Alnuaim, M. Firdausi, A. M. Mostafa, SEI2RS malware propagation model considering two infection rates in cyber-physical systems, Physica A, 597 (2022), 127207. https://doi.org/10.1016/j.physa.2022.127207 doi: 10.1016/j.physa.2022.127207
![]() |
[8] |
Z. H. Yu, S. Lu, D. Wang, Z. W. Li, Modeling and analysis of rumor propagation in social networks, Inf. Sci., 580 (2021), 857–873. https://doi.org/10.1016/j.ins.2021.09.012 doi: 10.1016/j.ins.2021.09.012
![]() |
[9] |
N. Perra, Non-pharmaceutical interventions during the COVID-19 pandemic: A review, Phys. Rep., 913 (2021), 1–52. https://doi.org/10.1016/j.physrep.2021.02.001 doi: 10.1016/j.physrep.2021.02.001
![]() |
[10] |
C. N. Ngonghala, E. Iboi, S. Eikenberry, M. Scotch, C. R. MacIntyre, M. H. Bonds, et al., Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus, Math. Biosci., 325 (2020), 108364. https://doi.org/10.1016/j.mbs.2020.108364 doi: 10.1016/j.mbs.2020.108364
![]() |
[11] |
Z. H. Yu, R. Arif, M. A. Fahmy, A. Sohail, Self organizing maps for the parametric analysis of COVID-19 SEIRS delayed model, Chaos Solitons Fractals, 150 (2021), 111202. https://doi.org/10.1016/j.chaos.2021.111202 doi: 10.1016/j.chaos.2021.111202
![]() |
[12] |
M. Jeyanathan, S. Afkhami, F. Smaill, M. S. Miller, B. D. Lichty, Z. Xing, Immunological considerations for COVID-19 vaccine strategies, Nat. Rev. Immunol., 20 (2020), 615–632. https://doi.org/10.1038/s41577-020-00434-6 doi: 10.1038/s41577-020-00434-6
![]() |
[13] |
T. J. Bollyky, US COVID-19 vaccination challenges go beyond supply, Ann. Intern. Med., 174 (2021), 558–559. https://doi.org/10.7326/M20-8280 doi: 10.7326/M20-8280
![]() |
[14] |
E. A. Iboi, C. N. Ngonghala, A. B. Gumel, Will an imperfect vaccine curtail the COVID-19 pandemic in the US?, Infect. Dis. Model., 5 (2020), 510–524. https://doi.org/10.1016/j.idm.2020.07.006 doi: 10.1016/j.idm.2020.07.006
![]() |
[15] |
B. Huang, J. H. Wang, J. X. Cai, S. Q. Yao, P. K. S. Chan, T. H. Tam, et al., Integrated vaccination and physical distancing interventions to prevent future COVID-19 waves in Chinese cities, Nat. Hum. Behav., 5 (2021), 695–705. https://doi.org/10.1038/s41562-021-01063-2 doi: 10.1038/s41562-021-01063-2
![]() |
[16] |
Y. K. Zou, W. Yang, J. J. Lai, J. W. Hou, W. Lin, Vaccination and quarantine effect on COVID-19 transmission dynamics incorporating Chinese-Spring-Festival travel rush: Modeling and simulations, Bull. Math. Biol., 84 (2022), 1–19. https://doi.org/10.1007/s11538-021-00958-5 doi: 10.1007/s11538-021-00958-5
![]() |
[17] | World Health Organization, Coronavirus disease (COVID-19): Variants of SARS-COV-2, 2022. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-variants-of-sars-cov-2. |
[18] | World Health Organization, Coronavirus disease (COVID-19): Vaccines, 2022. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccines. |
[19] |
T. T. Li, Y. M. Guo, Modeling and optimal control of mutated COVID-19 (Delta strain) with imperfect vaccination, Chaos Solitons Fractals, 156 (2022), 111825. https://doi.org/10.1016/j.chaos.2022.111825 doi: 10.1016/j.chaos.2022.111825
![]() |
[20] |
A. Truszkowska, L. Zino, S. Butail, E. Caroppo, Z. P. Jiang, A. Rizzo, et al., Predicting the effects of waning vaccine immunity against COVID-19 through high-resolution agent-based modeling, Adv. Theory Simul., (2022), 2100521. https://doi.org/10.1002/adts.202100521 doi: 10.1002/adts.202100521
![]() |
[21] | V. Lakshmikantham, S. Leela, A. A. Martynyuk, Stability analysis of nonlinear systems, Marcel Dekker, Inc., New York and Basel, 1989. https://doi.org/10.1007/978-3-319-27200-9 |
[22] |
P. Van den Driessche, J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Math. Biosci., 180 (2002), 29–48. https://doi.org/10.1016/S0025-5564(02)00108-6 doi: 10.1016/S0025-5564(02)00108-6
![]() |
[23] | O. Diekmann, J. A. P. Heesterbeek, J. A. J. Metz, O. Diekmann, On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations, J. Math. Biol., 28 (1990), 365–382. |
[24] | J. P. LaSalle, The stability of dynamical systems, Regional Conf. Ser. Appl. Math., SIAM, Philadelphia, 1976. |
[25] | Central Disaster Management Headquarters of Korea, 2021. Available from: http://ncov.mohw.go.kr. |
[26] | Our World in Data, 2021. Available from: https://ourworldindata.org/coronavirus#explore-the-global-situation. |
[27] | Korea Disease Control and Prevention Agency, 2021. Available from: https://www.kdca.go.kr/index.es?sid=a2. |
[28] | Central Disaster Management Headquarters of Korea, What is the criteria for releasing an asymptomatic person who tests positive for the virus from quarantine?, 2021. Available from: http://ncov.mohw.go.kr/en/faqBoardList.do?brdId=13&brdGubun=131&dataGubun=&ncvContSeq=&contSeq=&board_id=. |
[29] |
M. Zhang, J. P. Xiao, A. P. Deng, Y. T. Zhang, Y. L. Zhuang, T. Hu et al., Transmission dynamics of an outbreak of the COVID-19 Delta variant B. 1.617. 2–Guangdong Province, China, May–June 2021, China CDC Wkly, 3 (2021), 584–586. https://doi.org/10.46234/ccdcw2021.148 doi: 10.46234/ccdcw2021.148
![]() |
[30] |
M. Z. Yin, Q. W. Zhu, X. Lü, Parameter estimation of the incubation period of COVID-19 based on the doubly interval-censored data model, Nonlinear Dyn., 106 (2021), 1347–1358. https://doi.org/10.1007/s11071-021-06587-w doi: 10.1007/s11071-021-06587-w
![]() |
[31] |
N. Ferguson, D. Laydon, G. Nedjati-Gilani, N. Imai, K. Ainslie, M. Baguelin, et al., Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand, Imperial College London, 10 (2020), 491–497. https://doi.org/10.25561/77482 doi: 10.25561/77482
![]() |
[32] |
S. M. Kissler, C. Tedijanto, E. Goldstein, Y. H. Grad, M. Lipsitch, Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period, Science, 368 (2020), 860–868. https://doi.org/10.1126/science.abb5793 doi: 10.1126/science.abb5793
![]() |
[33] |
O. Byambasuren, M. Cardona, K. Bell, J. Clark, M. L. McLaws, P. Glasziou, Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis, J. Assoc. Med. Microbiol. Infect. Dis. Can., 5 (2020), 223–234. https://doi.org/10.3138/jammi-2020-0030 doi: 10.3138/jammi-2020-0030
![]() |
[34] |
R. Y. Li, S. Pei, B. Chen, Y. M. Song, T. Zhang, W. Yang, et al., Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2), Science, 368 (2020), 489–493. https://doi.org/10.1126/science.abb3221 doi: 10.1126/science.abb3221
![]() |
[35] | SOUTH KOREA, Average Lifespan, The information of average lifespan in South Korea, 2021. Available from: https://m.naver.com/. |
[36] | SOUTH KOREA, Population, The information of population in South Korea, 2021. Available from: https://m.naver.com/. |
[37] | World Health Organization, WHO target product profiles for COVID-19 vaccines, 2021. Available from: https://www.who.int/publications/m/item/who-target-product-profiles-for-covid-19-vaccines. |
[38] | Korea Disease Control and Prevention Agency, Are COVID-19 vaccinations effective, 2021. Available from: https://ncv.kdca.go.kr/menu.es?mid=a20102000000. |
[39] | Central Disaster Management Headquarters of Korea, 2021. Available from: http://ncov.mohw.go.kr/tcmBoardList.do?brdId=3&brdGubun=. |
[40] | Korea Disease Control and Prevention Agency, 2021. Available from: http://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015. |
[41] | Korea Disease Control and Prevention Agency, The outbreak and vaccination status of COVID-19 in Korea (8.23., as of 0: 00), 2021. Available from: https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=716586&cg_code =&act=view&nPage=20. |
[42] |
B. Tang, X. Wang, Q. Li, N. L. Bragazzi, S. Y. Tang, Y. N. Xiao, et al., Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions, J. Clin. Med., 9 (2020), 462. https://doi.org/10.3390/jcm9020462 doi: 10.3390/jcm9020462
![]() |
1. | Hyojung Lee, Sol Kim, Minyoung Jeong, Eunseo Choi, Hyeonjeong Ahn, Jeehyun Lee, Mathematical Modeling of COVID-19 Transmission and Intervention in South Korea: A Review of Literature, 2023, 64, 0513-5796, 1, 10.3349/ymj.2022.0471 | |
2. | Xinyu Bai, Shaojuan Ma, Stochastic dynamical behavior of COVID-19 model based on secondary vaccination, 2022, 20, 1551-0018, 2980, 10.3934/mbe.2023141 | |
3. | Youngsuk Ko, Victoria May Mendoza, Renier Mendoza, Yubin Seo, Jacob Lee, Eunok Jung, Risk estimation of lifted mask mandates and emerging variants using mathematical model, 2023, 9, 24058440, e16841, 10.1016/j.heliyon.2023.e16841 | |
4. | Junhyoung Kim, Suyoung Jo, Sung-il Cho, New framework to assess tracing and testing based on South Korea’s response to COVID-19, 2024, 24, 1471-2334, 10.1186/s12879-024-09363-4 | |
5. | Yanchao Liu, Pengzhou Zhang, Lei Shi, Junpeng Gong, A Survey of Information Dissemination Model, Datasets, and Insight, 2023, 11, 2227-7390, 3707, 10.3390/math11173707 | |
6. | Liqiong Jian, Xinyu Bai, Shaojuan Ma, Minyu Feng, Stochastic dynamical analysis for the complex infectious disease model driven by multisource noises, 2024, 19, 1932-6203, e0296183, 10.1371/journal.pone.0296183 | |
7. | Mlyashimbi Helikumi, Paride O. Lolika, Dynamics and analysis of COVID-19 disease transmission: The effect of vaccination and quarantine, 2023, 3, 2767-8946, 192, 10.3934/mmc.2023017 | |
8. | Komal Basaiti, Anil Kumar Vashishth, Tonghua Zhang, Modeling the effects of cross immunity and control measures on competitive dynamics of SARS-CoV-2 variants in the USA, UK, and Brazil, 2025, 00255564, 109450, 10.1016/j.mbs.2025.109450 |
State variable | Description |
Su | Population of non-quarantined susceptible individuals |
Sq | Population of quarantined susceptible individuals |
Vu | Population of non-quarantined vaccinated individuals |
Vq | Population of quarantined vaccinated individuals |
Eu | Population of non-quarantined exposed individuals |
Eq | Population of quarantined exposed individuals |
Iu | Population of non-hospitalized symptomatically-infectious individuals |
Ih | Population of hospitalized symptomatically-infectious individuals |
Ia | Population of asymptomatically-infectious individuals with mild or no clinical symptoms of the disease |
R | Population of recovered individuals |
Parameter | Description | Values |
c | Effective contact rate | 0.1 |
β | Probability of infection per contact | 0.5 |
q | Proportion of infectious individuals quarantined at time of exposure | 0.05 |
ξv | Vaccination rate (the reciprocal of the time during which everyone has completed vaccination) | 0.8 |
ηv | Rate of immunity loss after vaccination (1/ηv is the mean duration of vaccine immunity) | 0.56 |
εv | Ineffectiveness of vaccine against COVID-19 variants | 0.14 |
ηu | Modification parameter accounting for the relative infectiousness of individuals in the Eu compartment in relation to individuals in the Iu compartment (0<ηu<1) | 0.1 |
ηa | Modification parameter accounting for the relative infectiousness of individuals in the Ia compartment in relation to individuals in the Iu compartment (0<ηa<1) | 0.1 |
θ | Ineffectiveness of quarantine | 0.5 |
ω | Rate at which individuals in the Sq compartment revert to the Su compartment (1/ω is the duration of quarantine) | 0.5 |
αu | Rate at which individuals in the Eu compartment are detected and placed in quarantine | 0.116 |
1σu(1σq) | Latency period for non-quarantined (quarantined) exposed individuals | 5.1 |
σa | Rate at which individuals in the Ia compartment are detected and hospitalized | 0.309 |
f1 | Proportion of individuals in the Eu compartment who progress to the Iu compartment at the end of the incubation period (f1+f2<1) | 0.4 |
f2 | Proportion of individuals in the Eu compartment who progress to the Ih compartment at the end of the incubation period (f1+f2<1) | 0.2 |
1−f1−f2 | Proportion of individuals in the Eu compartment who progress to the Ia compartment | 0.4 |
r(1−r) | Proportion of individuals in the Eq compartment who move to the Ih (Ia) compartment | 0.7 |
ϕu | Hospitalization rate of individuals in the Iu compartment | 0.2 |
p1 | Modification parameter accounting for the relative release rate of individuals in the Vu compartment in relation to individuals in the Su compartment | 0.5 |
p2 | Modification parameter accounting for the relative quarantine rate of individuals in the Vu compartment in relation to individuals in the Su compartment | 1 |
γu | Recovery rate for individuals in the Iu compartment | 0.1 |
γh | Recovery rate for individuals in the Ih compartment | 0.125 |
γa | Recovery rate for individuals in the Ia compartment | 0.13978 |
δu | Disease-induced mortality rate for individuals in the Iu compartment | 0.015 |
δh | Disease-induced mortality rate for individuals in the Ih compartment | 0.015 |
δa | Disease-induced mortality rate for individuals in the Ia compartment | 0.075 |
Λ | Recruitment rate | 20 |
d | Natural death rate | 0.2 |
Parameter | Default values | Reference | Parameter | Default values | Reference |
Λ | 1704.41 | [35,36] | 1−f1−f2 | 0.15296 | [31,32,33] |
d | 1/(83.3×365) | [35] | r | 0.7 | [10] |
ξv | 7.6×10−3 | [39] | σa | 0.2435 | [10] |
ηv | 1/180 | [37] | ϕu | 1/5 | [10,31] |
εv | 0.134 | [38] | p1 | 1 0 | [27] |
ηu | 0.5 | Assumed | p2 | 1 0 | [27] |
ηa | 0.5 | [31,34] | γu | 1/10 | [10,31] |
θ | 0 | [28] | γh | 1/8 | [10,31] |
ω | 1/14 | [28] | γa | 0.13978 | [42] |
σu(σq) | 1/4.4 | [29] | δu | 0.00875 | [39] |
f1 | 0.80304 | [31,32,33] | δh | 0.00875 | [39] |
f2 | 0.044 | [31,32] | δa | 0.004375 | [39] |
Variable | Initial value | Reference |
Su | 39,465,104 | (1−ξ)(N(0)−Sq(0)−Vq(0)−Eu(0)−Eq(0)−Ih(0)−Iu(0)−Ia(0)−R(0)) |
Sq | 478,691 | Derived from the number of newly confirmed cases per day confirmed by temporary screening, ω and ξ |
Vu | 11,457,611 | ξ(N(0)−Sq(0)−Vq(0)−Eu(0)−Eq(0)−Ih(0)−Iu(0)−Ia(0)−R(0)) |
Vq | 138,975 | Derived from the number of newly confirmed cases per day confirmed by temporary screening, ω and ξ |
Eu | 1664 | Derived from Iu(0), Ia(0) and σu |
Eq | 4852 | Derived from the number of newly confirmed cases per day confirmed by temporary screening and σq |
Iu | 1751 | Derived from the proportion of symptomatically-infectious individuals, Ih(0) and ϕu |
Ih | 27,959 | Official data |
Ia | 333 | Derived from the proportion of asymptomatically-infectious individuals, Ih(0) and σa |
R | 244,729 | Derived from official data and the proportion of newly confirmed cases per day confirmed by temporary screening |
Parameter | Fitted value of the first stage | Fitted value of the second stage |
c | 10.7392 | 24.6129 |
β | 0.1037 | 0.1216 |
q | 0.7727 | 1 |
αu | 0.0714 | 0.3156 |
Fitting effect of the first stage | Fitting effect of the second stage | Prediction effect | |
MAPE | 0.23% | 0.22% | 0.047% |
State variable | Description |
Su | Population of non-quarantined susceptible individuals |
Sq | Population of quarantined susceptible individuals |
Vu | Population of non-quarantined vaccinated individuals |
Vq | Population of quarantined vaccinated individuals |
Eu | Population of non-quarantined exposed individuals |
Eq | Population of quarantined exposed individuals |
Iu | Population of non-hospitalized symptomatically-infectious individuals |
Ih | Population of hospitalized symptomatically-infectious individuals |
Ia | Population of asymptomatically-infectious individuals with mild or no clinical symptoms of the disease |
R | Population of recovered individuals |
Parameter | Description | Values |
c | Effective contact rate | 0.1 |
β | Probability of infection per contact | 0.5 |
q | Proportion of infectious individuals quarantined at time of exposure | 0.05 |
ξv | Vaccination rate (the reciprocal of the time during which everyone has completed vaccination) | 0.8 |
ηv | Rate of immunity loss after vaccination (1/ηv is the mean duration of vaccine immunity) | 0.56 |
εv | Ineffectiveness of vaccine against COVID-19 variants | 0.14 |
ηu | Modification parameter accounting for the relative infectiousness of individuals in the Eu compartment in relation to individuals in the Iu compartment (0<ηu<1) | 0.1 |
ηa | Modification parameter accounting for the relative infectiousness of individuals in the Ia compartment in relation to individuals in the Iu compartment (0<ηa<1) | 0.1 |
θ | Ineffectiveness of quarantine | 0.5 |
ω | Rate at which individuals in the Sq compartment revert to the Su compartment (1/ω is the duration of quarantine) | 0.5 |
αu | Rate at which individuals in the Eu compartment are detected and placed in quarantine | 0.116 |
1σu(1σq) | Latency period for non-quarantined (quarantined) exposed individuals | 5.1 |
σa | Rate at which individuals in the Ia compartment are detected and hospitalized | 0.309 |
f1 | Proportion of individuals in the Eu compartment who progress to the Iu compartment at the end of the incubation period (f1+f2<1) | 0.4 |
f2 | Proportion of individuals in the Eu compartment who progress to the Ih compartment at the end of the incubation period (f1+f2<1) | 0.2 |
1−f1−f2 | Proportion of individuals in the Eu compartment who progress to the Ia compartment | 0.4 |
r(1−r) | Proportion of individuals in the Eq compartment who move to the Ih (Ia) compartment | 0.7 |
ϕu | Hospitalization rate of individuals in the Iu compartment | 0.2 |
p1 | Modification parameter accounting for the relative release rate of individuals in the Vu compartment in relation to individuals in the Su compartment | 0.5 |
p2 | Modification parameter accounting for the relative quarantine rate of individuals in the Vu compartment in relation to individuals in the Su compartment | 1 |
γu | Recovery rate for individuals in the Iu compartment | 0.1 |
γh | Recovery rate for individuals in the Ih compartment | 0.125 |
γa | Recovery rate for individuals in the Ia compartment | 0.13978 |
δu | Disease-induced mortality rate for individuals in the Iu compartment | 0.015 |
δh | Disease-induced mortality rate for individuals in the Ih compartment | 0.015 |
δa | Disease-induced mortality rate for individuals in the Ia compartment | 0.075 |
Λ | Recruitment rate | 20 |
d | Natural death rate | 0.2 |
Parameter | Default values | Reference | Parameter | Default values | Reference |
Λ | 1704.41 | [35,36] | 1−f1−f2 | 0.15296 | [31,32,33] |
d | 1/(83.3×365) | [35] | r | 0.7 | [10] |
ξv | 7.6×10−3 | [39] | σa | 0.2435 | [10] |
ηv | 1/180 | [37] | ϕu | 1/5 | [10,31] |
εv | 0.134 | [38] | p1 | 1 0 | [27] |
ηu | 0.5 | Assumed | p2 | 1 0 | [27] |
ηa | 0.5 | [31,34] | γu | 1/10 | [10,31] |
θ | 0 | [28] | γh | 1/8 | [10,31] |
ω | 1/14 | [28] | γa | 0.13978 | [42] |
σu(σq) | 1/4.4 | [29] | δu | 0.00875 | [39] |
f1 | 0.80304 | [31,32,33] | δh | 0.00875 | [39] |
f2 | 0.044 | [31,32] | δa | 0.004375 | [39] |
Variable | Initial value | Reference |
Su | 39,465,104 | (1−ξ)(N(0)−Sq(0)−Vq(0)−Eu(0)−Eq(0)−Ih(0)−Iu(0)−Ia(0)−R(0)) |
Sq | 478,691 | Derived from the number of newly confirmed cases per day confirmed by temporary screening, ω and ξ |
Vu | 11,457,611 | ξ(N(0)−Sq(0)−Vq(0)−Eu(0)−Eq(0)−Ih(0)−Iu(0)−Ia(0)−R(0)) |
Vq | 138,975 | Derived from the number of newly confirmed cases per day confirmed by temporary screening, ω and ξ |
Eu | 1664 | Derived from Iu(0), Ia(0) and σu |
Eq | 4852 | Derived from the number of newly confirmed cases per day confirmed by temporary screening and σq |
Iu | 1751 | Derived from the proportion of symptomatically-infectious individuals, Ih(0) and ϕu |
Ih | 27,959 | Official data |
Ia | 333 | Derived from the proportion of asymptomatically-infectious individuals, Ih(0) and σa |
R | 244,729 | Derived from official data and the proportion of newly confirmed cases per day confirmed by temporary screening |
Parameter | Fitted value of the first stage | Fitted value of the second stage |
c | 10.7392 | 24.6129 |
β | 0.1037 | 0.1216 |
q | 0.7727 | 1 |
αu | 0.0714 | 0.3156 |
Fitting effect of the first stage | Fitting effect of the second stage | Prediction effect | |
MAPE | 0.23% | 0.22% | 0.047% |